Resource impact template
NICE has produced a resource impact template that incorporates the following technology appraisal guidance for chronic heart failure with preserved or mildly reduced ejection fraction:
- Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction (2023) NICE technology appraisal guidance 929
- Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction (2023) NICE technology appraisal guidance 902
This page was last updated: